Combined allergic rhinitis asthma syndrome
Conditions
Interventions
experimental group:Huanxiaozhiqiu decoction
Sponsors
Dongfang Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
6 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Children aged 6-14 years old. 2. The diagnostic criteria for CARAS in children were met, and the clinical stage was non-acute attack, in which the degree of asthma was graded as grade 3, and theTraditional Chinese Medicine pattern was "qi deficiency and phlegm stasis". 3. Parents and/or the child himself/herself (dual signatures required if =8 years of age) give informed consent to follow the physician's diagnostic and therapeutic arrangements and to voluntarily enroll in the study by signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Combined with serious respiratory infectious diseases; combined with serious primary diseases such as cardiovascular, hepatic, renal, endocrine or hematopoietic systems; combined with other nasal diseases such as sinusitis, vasomotor rhinitis, nasal polyps, deviated septum and so on. 2. Comorbid neurological or psychiatric disorders resulting in cognitive impairment or communication disorders. 3. Those who are unable to cooperate with the nitric oxide examination of exhaled breath; and those who are unable to cooperate with the examination of the pulmonary ventilation function of children due to the combination of otitis media perforation, pneumothorax, inguinal hernia, or ophthalmic surgery of the chest or abdomen in the past 1-3 months. 4. Allergic to therapeutic drugs. 5. Those who have received other relevant treatments that may affect the observed effects of this study or participated in other experimental studies within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function small airway indexes;disease control rate(%);CARAS symptom rating scales;constitution assessment of children with asthma;circumstance of respiratory infections; | — |
Secondary
| Measure | Time frame |
|---|---|
| asthma control test;allergic rhinitis symptom scales;other pulmonary ventilation indexes;FeNO test;visual analog scale;safety indicators; | — |
Countries
China
Contacts
Public ContactLiqun Wu
Dongfang Hospital Beijing University of Chinese Medicine
Outcome results
None listed